Page last updated: 2024-09-03

sc 51089 and mdl 100907

sc 51089 has been researched along with mdl 100907 in 1 studies

Compound Research Comparison

Studies (sc 51089)	Trials (sc 51089)	Recent Studies (post-2010) (sc 51089)	Studies (mdl 100907)	Trials (mdl 100907)	Recent Studies (post-2010) (mdl 100907)
41	1	19	1,241	65	539

Protein Interaction Comparison

Protein	Taxonomy	sc 51089 (IC50)	mdl 100907 (IC50)
5-hydroxytryptamine receptor 2A	Homo sapiens (human)		0.0048

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chiaia, N; Collins, SA; Gudelsky, GA; Huff, C; Yamamoto, BK	1

Other Studies

1 other study(ies) available for sc 51089 and mdl 100907

Article	Year
3,4-methylenedioxymethamphetamine increases excitability in the dentate gyrus: role of 5HT2A receptor-induced PGE2 signaling. Journal of neurochemistry, 2016, Volume: 136, Issue:5 Topics: Animals; Central Nervous System Stimulants; Dentate Gyrus; Dinoprostone; Glutamic Acid; Hippocampus; Hydrazines; Male; N-Methyl-3,4-methylenedioxyamphetamine; Neurons; Oxazepines; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Serotonin 5-HT2 Receptor Antagonists; Signal Transduction	2016

Article

Year

3,4-methylenedioxymethamphetamine increases excitability in the dentate gyrus: role of 5HT2A receptor-induced PGE2 signaling.

Journal of neurochemistry, 2016, Volume: 136, Issue:5

Topics: Animals; Central Nervous System Stimulants; Dentate Gyrus; Dinoprostone; Glutamic Acid; Hippocampus; Hydrazines; Male; N-Methyl-3,4-methylenedioxyamphetamine; Neurons; Oxazepines; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Serotonin 5-HT2 Receptor Antagonists; Signal Transduction

2016